Mousavi S M, Gouya M M, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z
Department of Community Medicine, Faculty of Medicine, Liver and Gastro Intestinal Diseases Research Center, Tabriz University of Medical Science, Tabriz, Iran.
Ann Oncol. 2009 Mar;20(3):556-63. doi: 10.1093/annonc/mdn642. Epub 2008 Dec 10.
Cancer is the third main cause of death in Iran. This report was provided for explaining cancer incidence and mortality.
The National Cancer Registry reports from 2003 to 2006, population-based cancer registry reports from five provinces in 2006 and National Death Registry reports from 1999 to 2004 have been applied in this report.
The age-standardized incidence rate of cancers was 98 and 110 per 100,000 among females and males. The male to female standard ratio was 1.12. The most common cancer among women and men was breast cancer (24) and stomach cancer (15), respectively. The estimated mortality rate for cancer was 41.1 and 65 per 100,000 for females and males in 2004.
The current low cancer incidence rates in Iran might be due to lack of national cancer screening programs for prostate, colorectal or breast cancer, a consequence of incomplete registration as well as incomplete diagnosis of cancer patients; it is expected that it will rise dramatically in the future because of anticipated increase in life expectancy and westernized lifestyle. The first priorities for health policy makers should be developing, establishing and implementing national cancer control; or else, the health system could not respond to the demands regarding to diagnosis, treatment and palliation for these patients in the future.
癌症是伊朗第三大主要死因。本报告旨在解释癌症的发病率和死亡率。
本报告采用了2003年至2006年的国家癌症登记报告、2006年五个省份基于人群的癌症登记报告以及1999年至2004年的国家死亡登记报告。
女性和男性的癌症年龄标准化发病率分别为每10万人98例和110例。男女标准化比例为1.12。女性和男性中最常见的癌症分别是乳腺癌(24例)和胃癌(15例)。2004年女性和男性的癌症估计死亡率分别为每10万人41.1例和65例。
伊朗目前较低的癌症发病率可能是由于缺乏针对前列腺癌、结直肠癌或乳腺癌的国家癌症筛查项目、登记不完整以及癌症患者诊断不完整所致;预计未来由于预期的预期寿命增加和西方化生活方式,发病率将大幅上升。卫生政策制定者的首要任务应该是制定、建立和实施国家癌症控制措施;否则,卫生系统未来将无法应对这些患者在诊断、治疗和缓解方面的需求。